Approaching Asia: Opportunities and Challenges for Western Healthcare Firms
With 60% of the world’s population and an economy that is becoming the locomotive for the world, Asia is now the promise land for global healthcare companies. Some find Asia to be a huge market, some find it strategic to run R&D there; in the mean time, some find themselves struggling in a constantly changing policy environment and are unprotected from the violation of their intellectual properties. � This panel brings up frontline experience and discusses the real lesson learned in field. It reflects on the past years that global firms have spent in Asia, and strives to shed some light on the future.:
Moderator
Sandra J. Dratler, Dr.PH, MS
Lecturer and Director of External Relations
Graduate Program in Health Management
Haas School of Business, UC Berkeley
Confirmed Panelists
- Patricia Turney, Director of R&D Strategic Operations, Amgen, Inc.
- George Baeder, Vice President, Monitor Group, Asia Pacific
- Benjamin Avancena, International Vice President, Johnson Medical Device
and Diagnostics, Greater China